Investing Profile

Ed Hurwitz

InvestorVC

Managing Director at MPM Capital

Photo of Ed Hurwitz, Managing Director at MPM Capital

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
MPM Capital Managing Director
$100K - $5.0M
$1.5M
10
$52.7M
CompanyStageDateRound SizeTotal Raised
ReCode Therapeutics
Series BOct 2021$80M
Series AMar 2020$80M
$160M
Co-investors: Peter Thompson (OrbiMed), Helen Kim (Vida Ventures), Rana Al-Hallaq (Pfizer Venture Investments)
Protego Biopharma
Series AOct 2021$51M
$51M
Co-investors: Helen Kim (Vida Ventures)
BioIntervene
Series AJan 2020$30M
$30M
Larimar Therapeutics
Series EDec 2013$45M
Series DDec 2012$21M
$130M
Co-investors: Bruce Booth (Atlas Venture)
Applied Genetics Technologies Corporation
Series BNov 2012$38M
$38M
Co-investors: Bill Harrington (Osage University Partners)
Foldrx Pharmaceuticals
Venture RoundJun 2010$29M
$29M
Co-investors: Heath Lukatch (Red Tree Venture Capital), Wei Li (Creacion Ventures)
Sunesis Pharmaceuticals
Post-IPO EquityApr 2009$44M
$44M
MacroGenics
Series CMay 2006$45M
$45M